Non-surgical treatment for people who have suffered a more severe form of haemorrhagic stroke could be on the cards if trials here and in the United States prove successful.

Researchers are testing a protein-based compound that reduces inflammation in the brain after injury. It would complement existing treatment for the affliction, which makes up about one-fifth of all stroke cases here but caused 44 per cent of all stroke-related deaths in 2016.